Rise in Pharmaceutical Applications to Foster Demand for Mass Spectrometers in Europe

Improved scan rates, higher resolution, and heightened sensitivity attract more verticals towards mass spectroscopy, finds Frost & SullivanLONDON, Jan. 13, 2020 /PRNewswire/ --A A recent analysis of the mass spectrometry (MS) market in Europe by Frost & Sullivan has revealed that the sector will continue to grow at a CAGR of 7.2%, reaching $1.9 billion by 2025 from $1.16 billion in 2018.A  An increasing need to test food authenticity and a rising number of use-case scenarios in pharma have emerged as the key trends driving growth in this sector.A  "The introduction of stringent regulations relevant to the environment, food, and drug quality has contributed to a spike in testing activity across industries in Europe," said Janani Balasundar, Research Analyst, Measurement and Instrumentation at Frost & Sullivan. "This has resulted in higher demand for faster and more accurate mass spectrometers, which is expected to push the market towards growth despite it being at a mature stage."Frost & Sullivan's latest research, Analysis of the European Mass Spectrometry Market, Forecast to 2025, examines the key factors and trends influencing growth in the mass spectrometry sector in Europe and offers a thorough country-wise market analysis. The report also provides detailed shipment, pricing, and revenue forecasts and elucidates the growth opportunities in this sector.For further information on this analysis, please visit:
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2020    »